Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell

Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA 23298, USA.
Journal of Allergy and Clinical Immunology (Impact Factor: 11.48). 07/2005; 115(6):1162-8. DOI: 10.1016/j.jaci.2005.02.022
Source: PubMed


MC(T) and MC(TC) types of human mast cells (MCs) are distinguished from one another on the basis of the protease compositions of their secretory granules, but their functional and developmental relationships have been uncertain.
These studies better define the functional properties and developmental relationship of MC(T) and MC(TC) cells.
Mast cells were dispersed from human skin and lung, purified with anti-Kit antibody, and separated into CD88+ and CD88- populations by cell sorting. These cells were evaluated by immunocytochemistry with antitryptase and antichymase mAbs; for chymase and tryptase mRNA by real-time RT-PCR; for conversion of MC(T) to MC(TC) cells during cell culture with recombinant human stem cell factor and recombinant human IL-6; and for degranulation and leukotriene C 4 (LTC 4 ) secretion when stimulated with anti-FcepsilonRI, substance P, C5a, and compound 48/80.
Mature MC(T) and MC(TC) cells were separated from one another on the basis of selective expression of CD88, the C5aR, on MC(TC) cells. Lung MC(T) cells had negligible levels of chymase mRNA and retained their MC(T) phenotype in culture. Mature MC(TC) cells from skin and lung degranulated in response to FcepsilonRI cross-linking, C5a, compound 48/80, and substance P. Lung MC(TC) cells released LTC 4 on activation, but no LTC 4 was detected when skin-derived MC(TC) cells were activated. MC(T) cells from lung degranulated and released LTC 4 in response to anti-FcepsilonRI and substance P, but not to C5a and compound 48/80.
These observations functionally distinguish MC(T) from MC(TC) types of human mast cells and suggest important differences that may affect their participation in diseases such as asthma and urticaria.

Download full-text


Available from: Carole A Oskeritzian, Aug 21, 2014
  • Source
    • "Mature MC TC from skin and lung, but not in mature MC T from lung, express C5aR (Oskeritzian et al. 2005). Mast cell phenotypic heterogeneity, reflected in their extensive range of sensitivity to activation, and the variations in stored and released mediators, underlies the array of responses mast cells are able to generate (Metcalfe et al. 1997; Galli et al. 2005b). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Since first described by Paul Ehrlich in 1878, mast cells have been mostly viewed as effectors of allergy. It has been only in the past two decades that mast cells have gained recognition for their involvement in other physiological and pathological processes. Mast cells have a widespread distribution and are found predominantly at the interface between the host and the external environment. Mast cell maturation, phenotype and function are a direct consequence of the local microenvironment and have a marked influence on their ability to specifically recognize and respond to various stimuli through the release of an array of biologically active mediators. These features enable mast cells to act as both first responders in harmful situations as well as to respond to changes in their environment by communicating with a variety of other cells implicated in physiological and immunological responses. Therefore, the critical role of mast cells in both innate and adaptive immunity, including immune tolerance, has gained increased prominence. Conversely, mast cell dysfunction has pointed to these cells as the main offenders in several chronic allergic/inflammatory disorders, cancer and autoimmune diseases. This review summarizes the current knowledge of mast cell function in both normal and pathological conditions with regards to their regulation, phenotype and role.
    Acta histochemica et cytochemica official journal of the Japan Society of Histochemistry and Cytochemistry 07/2014; 62(10). DOI:10.1369/0022155414545334 · 1.39 Impact Factor
  • Source
    • "Surprisingly, E7S also induced mast cell degranulation in a dosedependent manner. Similar to previous findings in primary human mast cells (Oskeritzian et al., 2005), compound 48/80 also induced degranulation in LAD2 cells (Fig. 1B). To determine the relevance of studies using human LAD2 cells for C3aP, E7, and E7S we tested their effects on degranulation of primary human CD34 + -derived mast cells. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Although human mast cells express G protein coupled receptors for the anaphylatoxin C3a, previous studies indicated that C3a causes mast cell degranulation, at least in part, via a C3a receptor-independent mechanism similar to that proposed for polycationic molecules such as compound 48/80. The purpose of the present study was to delineate the receptor specificity of C3a-induced degranulation in human mast cells. We found that C3a, a C3a receptor "superagonist" (E7) and compound 48/80 induced Ca(2+) mobilization and degranulation in a differentiated human mast cell line, LAD2. However, C3a and E7 caused Ca(2+) mobilization in an immature mast cell line, HMC-1 but compound 48/80 did not. We have previously shown that LAD2 cells express MrgX1 and MrgX2 but HMC-1 cells do not. To delineate the receptor specificity for C3a and compound 48/80 further, we generated stable transfectants expressing MrgX1 and MrgX2 in a rodent mast cell line, RBL-2H3 cells. We found that compound 48/80 caused degranulation in RBL-2H3 cells expressing MrgX1 and MrgX2 but C3a did not. By contrast, E7 activated RBL-2H3 cells expressing MrgX2 but not MrgX1. These findings demonstrate that in contrast to previous reports, C3a and compound 48/80 do not use a shared mechanism for mast cell degranulation. It shows that while compound 48/80 utilizes MrgX1 and MrgX2 for mast cell degranulation C3a does not. It further reveals the novel finding that the previously characterized synthetic peptide, C3a receptor "superagonist" E7 activates human mast cells via two mechanisms; one involving the C3a receptor and the other MrgX2.
    European journal of pharmacology 07/2011; 668(1-2):299-304. DOI:10.1016/j.ejphar.2011.06.027 · 2.53 Impact Factor
  • Source
    • "Among the inflammatory mediators released from mast cells, histamine remains the best characterized and most potent vasoactive mediator implicated in acute phase of hypersensitivity (Kim et al., 2005). Mast cell degranulation can also be elicited by non-immunologic stimulators such as neuropeptides, basic compounds, compliment components, and certain drugs (Oskeritizian et al., 2005). Compound 48/80 and polymers of basic amino acids are some of the most potent stimulator of mast cells and elicits the mast cell degranulation (Ennis et al., 1980). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chamomile is most popular used medicinal plant and extensively consumed as a tea or tisanes. Traditionally this plant was used for treatment of many ailments such as allergy disorders and inflammatory mediated diseases. We investigated the effects of anti-allergic activity of Matricaria recutita L. on mast cell mediated allergic models. The protective effect of methanol extract of Matricaria recutita against compound 48/80 induced anaphylaxis and pruritis models for acute phase of hypersensitivity reactions were carried out. The late phase hypersensitivity reactions by compound 48/80 induced mast cell degranulation and histamine release from blood along with serum nitric oxide (NO), rat peritoneal fluid nitric oxide (NO) and bronchoalveolar fluid nitric oxide (NO) levels were measured. The methanol extract of Matricaria recutita L. showed inhibitory effects on anaphylaxis induced by compound 48/80 and significant dose dependent anti-pruritis property was observed by inhibiting the mast cell degranulation. Mast cell membrane stabilization activity was also observed in compound 48/80 induced mast cell activation. Dose dependent reduction in the histamine release, along with decreased release of serum, rat peritoneal and BAL fluid nitric oxide (NO) levels were observed. These results suggest that the methanol extract of Matricaria recutita showed potent anti-allergic activity by inhibition of histamine release from mast cells.
    Journal of Ethnopharmacology 05/2011; 137(1):336-40. DOI:10.1016/j.jep.2011.05.029 · 3.00 Impact Factor
Show more